|A controlled trial of a human papillomavirus type 16 vaccine|
LA Koutsky, KA Ault, CM Wheeler, DR Brown, E Barr, FB Alvarez, ...
New England Journal of Medicine 347 (21), 1645-1651, 2002
|Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre …|
LL Villa, RLR Costa, CA Petta, RP Andrade, KA Ault, AR Giuliano, ...
The lancet oncology 6 (5), 271-278, 2005
|Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial|
DM Harper, EL Franco, C Wheeler, DG Ferris, D Jenkins, A Schuind, ...
The lancet 364 (9447), 1757-1765, 2004
|Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases|
SM Garland, M Hernandez-Avila, CM Wheeler, G Perez, DM Harper, ...
New England Journal of Medicine 356 (19), 1928-1943, 2007
|Sustained efficacy up to 4· 5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial|
DM Harper, EL Franco, CM Wheeler, AB Moscicki, B Romanowski, ...
The Lancet 367 (9518), 1247-1255, 2006
|Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a …|
J Paavonen, P Naud, J Salmerón, CM Wheeler, SN Chow, D Apter, ...
The Lancet 374 (9686), 301-314, 2009
|Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of …|
J Paavonen, D Jenkins, FX Bosch, P Naud, J Salmerón, CM Wheeler, ...
The Lancet 369 (9580), 2161-2170, 2007
|Improved amplification of genital human papillomaviruses|
PE Gravitt, CL Peyton, TQ Alessi, CM Wheeler, F Coutlee, A Hildesheim, ...
Journal of clinical microbiology 38 (1), 357-361, 2000
|Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method|
PE Gravitt, CL Peyton, RJ Apple, CM Wheeler
Journal of clinical microbiology 36 (10), 3020-3027, 1998
|Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined …|
EA Joura, S Leodolter, M Hernandez-Avila, CM Wheeler, G Perez, ...
The Lancet 369 (9574), 1693-1702, 2007
|Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double …|
M Lehtinen, J Paavonen, CM Wheeler, U Jaisamrarn, SM Garland, ...
The lancet oncology 13 (1), 89-99, 2012
|American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors|
D Saslow, PE Castle, JT Cox, DD Davey, MH Einstein, DG Ferris, ...
CA: a cancer journal for clinicians 57 (1), 7-28, 2007
|Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial|
C Mao, LA Koutsky, KA Ault, CM Wheeler, DR Brown, DJ Wiley, ...
Obstetrics & Gynecology 107 (1), 18-27, 2006
|Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18|
LL Villa, KA Ault, AR Giuliano, RLR Costa, CA Petta, RP Andrade, ...
Vaccine 24 (27-28), 5571-5583, 2006
|The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in …|
DR Brown, SK Kjaer, K Sigurdsson, OE Iversen, M Hernandez-Avila, ...
The Journal of infectious diseases 199 (7), 926-935, 2009
|Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide …|
HU Bernard, SY Chan, MM Manos, CK Ong, LL Villa, H Delius, CL Peyton, ...
Journal of Infectious Diseases 170 (5), 1077-1085, 1994
|Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.|
T Yamada, MM Manos, J Peto, CE Greer, N Munoz, FX Bosch, ...
Journal of virology 71 (3), 2463-2472, 1997
|Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis …|
CM Wheeler, X Castellsagué, SM Garland, A Szarewski, J Paavonen, ...
The lancet oncology 13 (1), 100-110, 2012
|Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts …|
Future I/II Study Group
The BMJ 341, 2010
|Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2|
PE Castle, M Schiffman, CM Wheeler, D Solomon
Obstetrics and gynecology 113 (1), 18, 2009